Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Qilu Pharmaceutical Research And Development Center Ltd

Clinical trials sponsored by Shanghai Qilu Pharmaceutical Research And Development Center Ltd, explained in plain language.

Not yet recruiting 1

New hope for hard-to-treat cancers: experimental drug enters human testing

Disease control Not yet recruiting

This early-phase study tests a new drug called QLS1317 in 120 adults with advanced solid tumors that have specific genetic changes (MSI-H or dMMR) and have stopped responding to standard treatments. The main goals are to find the safest dose and see if the drug can shrink tumors.…

Phase: PHASE1 • Sponsor: Shanghai Qilu Pharmaceutical Research and Development Center LTD • Aim: Disease control

Last updated May 11, 2026 20:37 UTC